Merz Aesthetics Taps Gwyneth Paltrow as the Global Face of Xeomin

September 24, 2020

Merz Aesthetics has announced a partnership with Oscar- and Emmy-award-winning actor, author and entrepreneur, Gwyneth Paltrow, for the launch of the company’s first global campaign for Xeomin (incobotulinumtoxinA). Xeomin (pronounced phonetically: Zeo-min) is an FDA-approved anti-wrinkle injection for frown lines that is purified to remove unnecessary proteins. Women have been using Xeomin for nearly 10 years to give wrinkles between the eyebrows a smoother appearance. As the global face of the brand, Paltrow joins Xeomin in standing with women who choose beauty on their own terms and do so with proven products.
Read more at Business Wire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • The Beauty Health Company (SKIN) Rebrands to SkinHealth Systems
    • Amazon Launches GLP-1 Weight Loss Program with One Medical
    • Botox Cosmetic’s “The Confidence Collective” to Empower 250 Women Entrepreneurs
    • Medical Spa Show 2027 Call for Presentations Now Open
    • FDA Warning Letter to Texas Medical Spa Signals Increased Compliance Enforcement